ELTX - CIK 0001601485
Elicio Therapeutics, Inc. (ELTX) reported revenue of $2.30M for fiscal year 2022, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2022 | $2.30M | -91.9% |
| FY 2021 | $28.31M | +883.1% |
| FY 2020 | $2.88M | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.